Evolution Wealth Advisors, LLC Kodiak Sciences Inc. Transaction History

Evolution Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$80.85 - $128.49 $2,425 - $3,854	-30 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$81.97 - $106.94 $3,688 - $4,812	-45 Reduced 60.0%	30 $3,000
Q2 2021 Jul 22, 2021	BUY	$77.2 - $126.54 $617 - $1,012	8 Added 11.94%	75 $7,000
Q4 2020 Feb 02, 2021	BUY	$60.78 - $154.03 $4,072 - $10,320	67 New	67 $10,000

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $341M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.